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SHORT REPORT
Leptomeningeal metastasis after surgical resection
of brain metastases
Taco C van der Ree, Diederik W J Dippel, C J J Avezaat, P A E Sillevis Smitt,
Charles J Vecht, Martin J van den Bent
Abstract
Objective—To determine the incidence
and risk factors for leptomeningeal me-
tastasis after surgery for brain metastasis
of solid tumors.
Methods—Review of the records of all
patients operated on for brain metastasis
between January 1990 and August 1995.
Results—In this period 28 patients under-
went surgery for brain metastasis, of
whom 27 were available for evaluation in
this study. Median survival after crani-
otomy was 11 months. Nine patients (33%)
developed leptomeningeal metastasis 2–13
months after surgery, which included six
of the nine patients operated on for poste-
rior fossa metastasis (p=0.05). In five
patients, leptomeningeal metastasis was
the only site of recurrence. Three patients
developed the leptomeningeal metastasis
as bulky tumour along the spinal cord,
which is a rare presentation. No other risk
factors for the development of leptome-
ningeal metastasis other than surgery for
posterior fossa metastasis were identified.
Conclusions—There is an increased risk
of leptomeningeal metastasis after sur-
gery for posterior fossa metastasis. Future
trials should consider the value of an
active approach to this complication in
these patients.
(J Neurol Neurosurg Psychiatry 1999;66:225–227)
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surgery
Randomised studies on patients with single
brain metastasis with absent or controlled
extracranial tumour activity have shown a
longer survival after resection followed by
radiation therapy compared with radiation
therapy alone.1 In his monograph, Posner
mentions the development of leptomeningeal
metastasis as one of the unresolved questions in
surgical therapy for brain metastasis.2 In one
study 38% of patients developed leptomenin-
geal metastasis after surgery for a cerebellar
metastasis, but only 4.7% of patients treated
for a supratentorial metastasis.3 An increased
incidence of spinal intradural metastasis after
surgery for posterior fossa metastasis was also
briefly mentioned in an older publication.4 By
contrast, another series with a larger pro-
portion of patients treated for infratentorial
metastasis reported only 5.5% leptomeningeal
recurrences.5 However, most series on surgery
for brain metastasis did not consider such
recurrences. To determine the incidence of
leptomeningeal metastasis after surgery for
brain metastasis, we reviewed the records of all
patients who had undergone brain metastasis
resection in a 5.5 year period at the Daniel den
Hoed Cancer Center (DHCC) in Rotterdam.
Patients and methods
METHODS
The records of all patients with brain metasta-
sis from solid tumours treated at the DHCC in
the period January 1990 to August 1995 were
reviewed. Evaluable for this study were patients
treated at the DHCC at the time of resection or
radiation therapy of brain metastasis. Patients
referred to the DHCC at a later stage of their
disease (for example, for leptomeningeal dis-
ease) were excluded. We recorded the primary
tumour histology, location of brain metastasis
(supratentorial v infratentorial), depth of me-
tastasis (superficial<1cm; deep>cm), extent of
resection, postoperative therapy, diagnosis of
leptomeningeal metastasis, and interval be-
tween resection and diagnosis of leptomenin-
geal metastasis. The extent of resection was
based on the peroperative judgement of the
neurosurgeon, not on postoperative imaging.
The diagnosis of leptomeningeal metastasis
was made if malignant cells were present in the
CSF, or in the presence of typical neuroimag-
ing findings, such as leptomeningeal enhance-
ment extending in cerebral sulci or spinal
intradural extramedullary tumour deposits.6
The survival and leptomeningeal metastasis
free survival were calculated from the date of
surgery to the time of study (October 1996) or
to the date of death, using Kaplan-Meier
survival analysis. The eVect of clinical variables
on survival and leptomeningeal metastasis free
survival was assessed by the log rank test. The
level of statistical significance was taken as
p<05 (two sided).
PATIENTS
Twenty eight patients were treated with surgery
for brain metastasis between January 1990 and
August 1995. One patient, who died from car-
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diopulmonary failure 10 days after surgery, was
excluded from further analysis. The clinical
characteristics of the remaining 27 patients are
shown in the table. Four patients had some
evidence of progressive systemic disease at the
time of surgery, which was considered of minor
clinical importance. No patient was suspected
of having leptomeningeal metastasis at physical
examination or neuroimaging at the time of
surgery. Brain metastasis was located supraten-
torially in 18 patients, nine patients were oper-
ated on for infratentorial lesions. Twenty five
patients received adjuvant whole brain radio-
therapy. Several radiation fraction schedules
were used, 19 patients received an additional
boost to the tumour. Two patients were not
irradiated. One patient with small cell lung
cancer received systemic chemotherapy. The
other patient was operated on for a local recur-
rence of a solitary brain metastasis 6 months
after radiation therapy.
Results
Follow up was complete in all patients. Median
survival after resection of brain metastasis was
11 months (range 2 to 73 months), six patients
were still alive at the time of final analysis. Nine
of the 27 patients (33.3%) developed leptome-
ningeal metastasis. The 2 year leptomeningeal
metastasis free survival was 54% (95% CI
27%–75%, fig 1). In five patients, the leptome-
ningeal metastasis was cytologically confirmed.
In the other four patients the MRI showed
typical abnormalities of leptomeningeal metas-
tasis. In three of the nine patients with
leptomeningeal metastasis MRI showed bulky
intradural extramedullary tumour at the level
of the cervical or thoracic spinal cord (fig 2).
Nine patients had an infratentorial location
of metastasis, six of these developed leptome-
ningeal metastasis. Three of the 18 patients
(16,7%) with a supratentorial metastasis were
diagnosed with leptomeningeal metastasis. The
leptomeningeal metastasis free survival was
significantly shorter in patients with an in-
fratentorial lesion (fig 1, p=0.05, log rank). The
extent of resection of brain metastasis, the
extent of systemic disease, or treatment with an
additional radiation boost were not related to
development of leptomeningeal metastasis.
In five patients the leptomeningeal metasta-
sis was the only site of recurrence of metastatic
cancer after surgical removal of the brain
metastasis. The other four patients had concur-
rent systemic or cerebral tumour recurrence
(local or distant), either before or at the same
time as the diagnosis of leptomeningeal metas-
tasis. Median survival after diagnosis of lep-
tomeningeal metastasis was 5 months (range 1
Clinical characteristics of 27 patients with resection of brain
metastasis
Sex
Male 16
Female 11
Age at resection:
Median (range) 49 (29-70)
Primary tumour:
Lung 8
Genitourinary 6
Melanoma 6
Breast 5
Gastrointestinal 2
Location of brain metastasis:
Supratentorial 18
Infratentorial 9
Depth of BM:
Superficial (<1 cm) 14
Deep (>1 cm) 9
Unknown 4
Extent of resection
Total 23
Subtotal 4
Figure 1 Survival, leptomeningeal metastasis free
survival in the whole group, and leptomeningeal metastasis
free survival after surgery for infratentorial and
supratentorial brain metastasis.
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Figure 2 Gadolinium enhanced MRI of the spine,
showing bulky intradural, extramedulary metastasis at the
level of the 5th and 6th thoracic vertebral bodies (arrow).
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to 58 months). At the time of this study two
patients with leptomeningeal metastasis were
still alive, 5 and 58 months after diagnosis.
Discussion
Leptomeningeal metastasis is a relatively infre-
quent complication of solid tumours. The most
common solid tumours associated with it are
breast cancer, melanoma, and small cell lung
cancer.7 8 Most patients with leptomeningeal
metastasis have advanced disease, only rarely is
it the initial or sole presentation of cancer. In
this group of 27 patients treated with surgery
for brain metastasis nine patients (33%) devel-
oped leptomeningeal metastasis, in five of them
this was the only site of relapse. The risk of
leptomeningeal metastasis was significantly
higher in patients operated on for an infraten-
torial metastasis. Although in four patients the
leptomeningeal metastasis was not cytologi-
cally proved, we do not doubt the diagnosis as
the MRI showed typical abnormalities using
the criteria proposed by Freilich et al.6 Despite
the high frequency of leptomeningeal metasta-
sis, the median survival of 11 months after sur-
gery in this group is comparable with other
series on surgery for a single brain
metastasis.1 3 5
The incidence of leptomeningeal metastasis
in this study population exceeds that reported
in studies on leptomeningeal metastasis in a
cancer population. The crucial question is
whether our findings should be regarded as a
consequence of surgery or that they can be
explained otherwise. With longer survival after
surgery for solitary brain metastasis, patients
are longer at risk of developing a leptomenin-
geal recurrence, but our data exceed the 3 year
actuarial risk of 25% for leptomeningeal
metastasis as found in small cell lung cancer.9
Tumours that metastasise to the brain also pre-
dispose for leptomeningeal metastasis, and the
frequency is increased in posterior fossa metas-
tasis. However, the incidence of leptomenin-
geal metastasis after surgery for posterior fossa
brain metastasis which we found exceeds the
reported 25% 1 year actuarial risk for spinal
intradural seeding in fossa posterior
metastasis.10 Another explanation for our find-
ings is that leptomeningeal metastasis already
existed at the time of surgery, or alternatively,
that the fossa posterior tumours were in fact
leptomeningeal metastasis. However, none of
the patients had clinical signs or symptoms of
leptomeningeal metastasis at the time of
surgery.
On the other hand, intraoperative tumour
spill is a well recognised complication of surgi-
cal oncology, and this may of course also hap-
pen during surgery for brain metastasis.11 Our
series oVers two more arguments for a relation
with the surgical intervention. Firstly, leptome-
ningeal metastasis was a solitary recurrence in
five of nine patients, whereas most patients
with leptomeningeal metastasis develop this
while having widely metastasised cancer. Sec-
ondly, in three of our patients MRI of the spine
showed bulky intradural extramedullary
tumour at the level of cervical or thoracic spinal
cord (fig 2). In our experience, this is an
uncommon presentation of leptomeningeal
metastasis. A similar presentation of leptome-
ningeal metastasis after brain metastasis sur-
gery was described by Norris et al.12 We think
that these intradural metastases were due to
drop metastasis, arrested along the spinal cord.
Our results are in agreement with two other
studies, in which a 33%–38% incidence of lep-
tomeningeal metastasis after removal of poste-
rior fossa brain metastasis was reported.3 4
Recently, another series reported leptomenin-
geal metastasis in four out of 10 patients oper-
ated on for infratentorial metastasis, by con-
trast with only one of 55 patients operated on
for supratentorial metastasis.12 The increased
risk of leptomeningeal metastasis after surgery
for posterior fossa metastasis may be due to the
more intimate contact with the subarachnoid
space and the cisterna magna, which may oVer
a nidus for tumour cells not present over the
cerebral hemisphere.3
These data support a postoperative screen-
ing for leptomeningeal metastasis after surgery
for fossa posterior metastasis. If tumour cells
are present, further treatment may be consid-
ered (either intrathecal chemotherapy in
chemotherapy sensitive tumours, or neuraxis
radiation in tumours resistant to chemo-
therapy). Future trials are needed to show
whether this would be useful and to define the
role of these measures.
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